Edwards Lifesciences Corporation provided earnings guidance for the second quarter of 2024. For the quarter, the company projects total sales to be between $1.62 billion and $1.70 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.25 USD | -2.30% | +0.09% | +18.36% |
20/06 | Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing | MT |
17/06 | Edwards Lifesciences Corporation Announces Executive Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.36% | 55.66B | |
+2.06% | 211B | |
+5.69% | 185B | |
+29.31% | 158B | |
+2.36% | 64.32B | |
-1.92% | 48.41B | |
-8.37% | 37.82B | |
-1.37% | 35.57B | |
+8.67% | 28.12B | |
+15.02% | 23.58B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences Corporation Provides Earnings Guidance for the Second Quarter of 2024